Abstract:BACKGROUND Nonanimal stabilized hyaluronic acid (HA) dermal fillers are used to treat moderate to severe facial wrinkles and folds. Trials of HA generally have included few patients with pigmented skin. OBJECTIVE To compare the efficacy and tolerability of small‐gel‐particle (SGP) and large‐gel‐particle (LGP) HA in correcting nasolabial folds in patients with Fitzpatrick skin types IV to VI. METHODS AND MATERIALS One hundred fifty patients with Fitzpatrick skin types IV to VI received one treatment with SGP and LGP HA. Investigators and patients evaluated efficacy using palpability assessments and change from baseline Wrinkle Severity Rating Scale (WSRS) score at 2, 6, 12, and 24 weeks. RESULTS According to investigator evaluation, LGP HA reduced wrinkles by at least 1 WSRS grade in 95% of patients at 6 weeks and in 92% at 12 weeks, and SGP HA reduced wrinkles by at least 1 WSRS grade in 96% of patients at 6 weeks and in 93% at 12 weeks. Both fillers endured for at least 24 weeks. Patient assessments were 86% and 85% for LGP HA at 6 and 12 weeks, respectively, and 88% and 86% for SGP HA, respectively. Both fillers were well tolerated. Pigmentation changes occurred in 6% and 9% of patients treated with LGP and SGP HA, respectively. There were 17 cases of hyperpigmentation. Pigmentation changes occurred in 7% of patients with skin type IV, 13% with skin type V, and 13% with skin type VI. Most were mild or moderate and resolved within 12 weeks, except for three patients with postinflammatory hyperpigmentation. There were three reported mass formations, two of which were infectious in nature. CONCLUSION Variable‐particle HA fillers are effective and well tolerated in patients with skin of color. Medicis Aesthetics Inc. (Scottsdale, AZ) sponsored this study and provided the Restylane and Perlane used. Study funding was also provided to the authors and investigators, as was the contribution of medical writer Barbara Huber, BA, a consultant and writer for Premier Healthcare Resource, Inc., Morristown, NJ.

Effectiveness and Safety of Resilient Hyaluronic Acid (RHA) Dermal Fillers for the Correction of Moderate-to-Severe Nasolabial Folds in People of Color: Post Hoc Subgroup Analyses of US Pivotal Clinical Data

Efficacy and Safety of Two Resilient Hyaluronic Acid Fillers in the Treatment of Moderate-to-Severe Nasolabial Folds: A 64-Week, Prospective, Multicenter, Controlled, Randomized, Double-Blinded, and Within-Subject Study.

Efficacy of Variable‐Particle Hyaluronic Acid Dermal Fillers in Patients with Skin of Color: A Randomized, Evaluator‐Blinded Comparative Trial

A Randomized, Multicenter Study on a Flexible Hyaluronic Acid Filler in Treatment of Moderate-to-severe Nasolabial Folds in a Chinese Population

Efficacy and safety of a new monophasic hyaluronic acid filler in the correction of nasolabial folds: a randomized, evaluator-blinded, split-face study

A randomized, split-face, double-blind, comparative study of the safety and efficacy of small- and large-particle hyaluronic acid fillers for the treatment of nasolabial folds

A Randomized Clinical Trial of Comparing Monophasic Monodensified and Biphasic Nonanimal Stabilized Hyaluronic Acid Dermal Fillers in Treatment of Asian Nasolabial Folds

Safety and efficacy of hyaluronic acid for the correction of nasolabial folds: a meta-analysis.

A Multi-Center Comparative Efficacy and Safety Study of Two Different Hyaluronic Acid Fillers for Treatment of Nasolabial Folds in a Chinese Population.

Efficacy and durability of two hyaluronic acid-based fillers in the correction of nasolabial folds: results of a prospective, randomized, double-blind, actively controlled clinical pilot study

A Multicenter Noninferiority Study Comparing Safety and Effectiveness of Hyaluronic Acid Fillers for Correction of Nasolabial Folds in Chinese Subjects

The Efficacy and Safety of DermalaxTM DEEP in the Correction of Moderate to Severe Nasolabial Folds: a Multicenter, Randomized, Double-Blind Clinical Study.

Clinical efficacy and safety of hyaluronic acid dermal filler in treating nasolabial folds in Chinese population

Clinical Comparison Between Two Hyaluronic Acid-Derived Fillers in the Treatment of Nasolabial Folds in Chinese Subjects: BioHyalux Versus Restylane.

A multicenter, randomized, double-blind clinical study to evaluate the efficacy and safety of a new monophasic hyaluronic acid filler with lidocaine 0.3% in the correction of nasolabial fold

Efficacy and Safety of Fillers for the Treatment of Nasolabial Folds: A Network meta-Analysis of Randomized Controlled Trials

A Multi-Center Study of Restylane for Treatment of Nasolabial Folds in China

A Randomized, Evaluator-Blinded, Multi-Centered Study to Compare Injectable Poly-D, L-Lactic Acid Versus Hyaluronic Acid for Nasolabial Fold Augmentation

Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI

Long-term Safety and Effectiveness of Hyaluronic Acid Fillers Correcting Nasolabial Folds in Chinese Patients

Efficacy and Safety of 3 New Resilient Hyaluronic Acid Fillers, Crosslinked With Decreased BDDE, for the Treatment of Dynamic Wrinkles: Results of an 18-Month, Randomized Controlled Trial Versus Already Available Comparators.